Details
| Name | Htra2 |
| Type | gene |
| Species | Homo sapiens |
| Tissue | NA |
| Experiment Method | CRISPR/Cas9 |
| Up/Down | NA |
| Pro/Anti | Pro |
| Funtion Description | CRISPR/Cas9 technology has tremendous potential to become a new therapeutic modality for acquired non-inherited sensorineural hearing loss. |
| Regulation Gene | NA |
| Year | 2021 |
| Pubmed ID | 33752742 |
| Title | Prevention of acquired sensorineural hearing loss in mice by in vivo Htra2 gene editing |
| Drug | NA |
| Disease | NA |
| Environment Factors | NA |
| Circulating | NA |
| Variant | NA |
| High-throughput | NA |